3Rigat B, Hubert C, Alhenc GF, et al. An insertion/deletion polymorphism in the angiotensin I-con-verting enzyme gene accounting for half the variance of serum enzyme levels.J Clin Invest, 1990, 86: 1343.
4姚泰主编.生理学.第6版.北京:人民卫生出版社,2006.123.
5Wolf G. Link Between Angiotensin Ⅱ and TGF-β in the Kidney. Miner Elect Metab, 1998, 24: 174.
6Gilbert RE, Cox A, Wu LL, et al. Expression of transforming growth factor- betal and type IV collagen in the renaltubulointerstitium in experimental diabetes: effects of ACEinhibition. Diabetes. 1998. 47: 414-422.
7Arima S, Endo Y, Yaoita H, et al. Possible role of P-450 metabolite of arachidonic acid in vasodilatormechanism of angiotensin Ⅱ type 2 recep-tor in the isolated and microperfused rabbit afferent arteriole. J Clin Invest, 1997, 98: 2816.
8Paula RD, Lima CV, Khosla MC, et al. Angiotensin-( 1-7 ) potentiates the hy-potensive effect of bradykinin in con-scious rats. Hypertension, 1995, 26:1154-1159.
9Herbert L, Jackman MG, Massad MS, et al. Angiotensin- (1-9) and angiotensin-(1-7) realease in human heart role of cathepsin A. Hypertension, 2002, 39:976-981.
10Tran YL, Forster C. Angiotensin-(1-7) and the rataorta: Modulation by the en-dothelium. J Cardiol Pharmaco, 1997, 30: 676-682.
